Home›Companies›Upstream Biotechnology

Upstream Biotechnology, Inc.

Updated Oct 29, 2026·Latest SEC filing Sep 17, 2025·Suggest an edit

About Upstream Biotechnology

Upstream Biotechnology is a private company based in Durham, North Carolina. It has reported $625,000 raised in one offering on Form D since September 2025. Its chief executive is George Greene.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 26, 2025Sep 17, 2025$625,000of $1.6M target3$208KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Upstream Biotechnology's Form D filed Sep 17, 2025.

KL
Karen LeVert
Director
XW
GG
George Greene
Chief Executive Officer and director
XD
Xinnian Dong
Director

Sources

  1. SECUpstream Biotechnology, Inc. filing history